Acta dermato-venereologica最新文献_第4页

A Long Way to Diagnosis: Linear IgA Dermatosis Mimicking Prurigo Pigmentosa. 诊断之路还很长：线性IgA皮肤病模拟色素性痒疹。

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-09-07 DOI: 10.2340/actadv.v106.adv-2026-0686

Ann Giordano-Rosenbaum, Almut Böer-Auer, Enno Schmidt, Christian Rose

引用次数: 0

Prevalence of Genodermatoses in Finland from 1995 to 2022: A Nationwide Registry Study. 1995年至2022年芬兰遗传性皮肤病患病率：一项全国性登记研究

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-09-07 DOI: 10.2340/actadv.v106.adv-2026-0517

Sanni Kunnari, Suvi-Päivikki Sinikumpu, Jari Jokelainen, Laura Huilaja

引用次数: 0

Congenital Palmoplantar Keratoderma and Woolly Hair in a Child: A Quiz. 儿童先天性掌足底角化病和毛毛：一个小测验。

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-09-07 DOI: 10.2340/actadv.v106.adv-2026-0905

Lucie Harpain, Christiane Pees, Julian Heno, Sonja Radakovic

引用次数: 0

Upadacitinib Induces Rapid Remission in Refractory Eosinophilic Pustular Folliculitis with Facial Involvement: A Case Report. Upadacitinib诱导面部受累的难治性嗜酸性脓疱性毛囊炎快速缓解：Aa例报告。

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-09-02 DOI: 10.2340/actadv.v106.adv-2026-0701

Yanan Wang, Jinxuan Su, Hongzhong Jin

引用次数: 0

Temporal Inflammatory Profile in Skin Surface after Oronasal Mask Application. 应用口鼻口罩后皮肤表面的暂时性炎症特征。

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-08-31 DOI: 10.2340/actadv.v106.adv-2025-0159

Amanda Feldt, William Lövfors, Elin Nyman, Peter R Worsley, Bijar Ghafouri, Sara Bergstrand

{"title":"Temporal Inflammatory Profile in Skin Surface after Oronasal Mask Application.","authors":"Amanda Feldt, William Lövfors, Elin Nyman, Peter R Worsley, Bijar Ghafouri, Sara Bergstrand","doi":"10.2340/actadv.v106.adv-2025-0159","DOIUrl":"10.2340/actadv.v106.adv-2025-0159","url":null,"abstract":"Skin damage from routine oronasal facemask use is common, but the early molecular changes and timing of inflammatory cytokine responses remain poorly characterized due to limitations in conventional detection methods. Early pressure ulcer formation involves a critical window where physiological changes occur before visible signs. This study addresses this gap, aiming to monitor the temporal inflammatory profile in skin sebumsurface after the standard use of oronasal facemasks. Sebum samples were collected from 11 patients at six6 timepoints up to 180 min post-mask removal. A panel of 71 inflammatory proteins was analysed using multivariate statistics, protein network analysis, and mathematical modelling. Two distinct cytokine response phases were identified: an early phase (0-20 min) and a delayed phase (40-180 min), with 17 cytokines driving this separation. Notably, the delayed phase showed sustained elevation despite the absence of visible erythema, indicating ongoing subclinical inflammation. Network analysis revealed activation of pathways related to angiogenesis, cell death regulation, and tissue remodelling - hallmarks of early wound healing and microvascular stress. These findings enhance understanding of early pressure ulcer pathophysiology, identify optimal biomarker sampling windows, and support the development of point-of-care biosensors for early detection and prevention of pressure-induced skin damage.","PeriodicalId":6944,"journal":{"name":"Acta dermato-venereologica","volume":"106 ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13527610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148862964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Artificial Daylight Photodynamic Therapy with Methyl Aminolevulinate Using an Abbreviated Illumination Protocol with the MultiLite Lamp System in Patients with Actinic Keratoses. 使用短照度和多灯系统的氨酰酸甲酯人工日光光动力疗法治疗光化性角化病患者。

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-08-27 DOI: 10.2340/actadv.v106.adv-2026-0611

Mokone Mengis, Wolfgang G Philipp-Dormston

引用次数: 0

Patient Expectations and Perceived Treatment Benefit in Dermatology: A Sex-specific Analysis in Routine Dermatological Care. 皮肤科患者期望和治疗获益：常规皮肤科护理的性别特异性分析。

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-08-27 DOI: 10.2340/actadv.v106.adv-2026-0668

Sarah Preis, Lucia Westphal, Tilo Biedermann, Sophia Horster, Alexander Zink

引用次数: 0

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-08-27 DOI: 10.2340/actadv.v106.adv-2026-0553

Célia Delesalle, Aude Huitric, Emilie Brenaut, Laurent Misery, Claire Abasq-Thomas

引用次数: 0

A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis. 关于Tildrakizumab给药和滴定治疗中重度斑块型银屑病的德尔菲共识

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-08-27 DOI: 10.2340/actadv.v106.adv-2026-0593

Julia-Tatjana Maul, Maria Concetta Fargnoli, Spyridon Gkalpakiotis, Jo Lambert, Andreas Pinter, Ricardo Ruiz-Villaverde, Paul Sator, Thrasyvoulos Tzellos

{"title":"A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis.","authors":"Julia-Tatjana Maul, Maria Concetta Fargnoli, Spyridon Gkalpakiotis, Jo Lambert, Andreas Pinter, Ricardo Ruiz-Villaverde, Paul Sator, Thrasyvoulos Tzellos","doi":"10.2340/actadv.v106.adv-2026-0593","DOIUrl":"10.2340/actadv.v106.adv-2026-0593","url":null,"abstract":"Tildrakizumab is approved for moderate-to-severe plaque psoriasis in 2 doses, 100 mg and 200 mg, with comparable safety profiles. This study aimed to establish pan-European consensus on optimal tildrakizumab dosing and titration using a modified Delphi methodology. A steering group of 8 European dermatologists developed 48 consensus statements addressing tildrakizumab prescribing, dose selection and titration. The statements were incorporated into an online Likert survey and distributed across 9 European countries to experienced dermatologists. Consensus was predefined as ≥75% agreement. Seventy-two dermatologists completed the survey. Consensus was achieved for 35/48 statements (73%). Based on the results, initiation with the 100 mg dose may be considered in patients weighing <90 kg with a body mass index <25, moderate disease severity or who are biologic-naïve. Initiation with the 200 mg dose may be considered in patients weighing ≥90 kg and/or with a body mass index ≥25, severe disease, high-impact area involvement in the context of severe disease, prior interleukin-23p19 inhibitor failure or failure of ≥2 biologics. Up-titration to 200 mg may be considered for suboptimal response, while down-titration to 100 mg may be considered after ≥1 year of sustained remission. Adoption of this guidance may facilitate more consistent, individualized dosing and improved patient outcomes.","PeriodicalId":6944,"journal":{"name":"Acta dermato-venereologica","volume":"106 ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13520585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148823700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis. Spesolimab治疗广泛性脓疱性银屑病后c反应蛋白和中性粒细胞计数的早期时间解离。

IF 3.8 4区医学

Acta dermato-venereologica Pub Date : 2026-08-25 DOI: 10.2340/actadv.v106.adv-2026-0804

Ayu Watanabe, Masahiro Kamata, Yoshiki Okada, Kotaro Hayashi, Yayoi Tada

引用次数: 0